Psychemedics Inc (PMD): Growth-Adjusted Market Cap to Net Income

Corporate company logo of Psychemedics (PMD)

Psychemedics scalability is based on the automation of hair tests, which reduces costs as sample volumes increase. The PEG ratio clearly demonstrates this trend, and the current figure has reached 0.00. Stable cash flow combined with zero debt guarantees the fulfillment of all obligations. Service efficiency is further enhanced by logistics outsourcing and cloud data storage.

Psychemedics Corp (PMD): Price/Earnings to Growth Ratio from 07/04/2022 to 12/21/2024

Metric breakdowns and analytics for Psychemedics (PMD)

- current quotes and average value forecast:
Market Price Psychemedics Corp.|PMD - Price Target Chart
- stock exchange capitalization data:
Market Capitalization Psychemedics Corp|PMD - Enterprise Value
- company book value details:
Net Assets per Share Psychemedics|PMD - Company Book Value|Market Capitalization to Book Value psychemedics.com|PMD - Aggregate Company Assets
- debt obligations and liquidity statistics:
Aggregate Debt to Equity Psychemedics|PMD - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient psychemedics.com|PMD - Company Total Debt|Debts to Book Value Psychemedics Corp|PMD - Company Long-Term Debts|Company Current Liabilities Psychemedics|Intermediate Coverage Ratio psychemedics.com
- net income and valuation ratios data:
PMD - Net Profit|Expected Net Profit Psychemedics|PMD - Price to Earnings Ratio|Projected Price to Earnings Psychemedics Inc|PMD - PEG Multiple|Company Value to EBITDA Psychemedics Corp|PMD - Operating profit EBITDA|Earnings per share for the last 12 months Psychemedics|PMD - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months psychemedics.com|PMD - Earnings growth in current year|Expected earnings per share growth for next year Psychemedics
Summary company analytics:PMD - Psychemedics Corp.
Flagship merchandise of Psychemedics Corporation

An analysis of the weighted PEG ratio for Psychemedics (PMD) demonstrates a current value of 0.00, reflecting the balance between market valuation and net income dynamics. A decline in this ratio below one signals that the asset is undervalued; however, for this laboratory, the risk of margin compression due to clients switching to budget rapid tests could turn a formal discount into a value trap.

Competing companies

A - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Quest DGX|Growth-Adjusted Market Cap to Net Income Illumina Platform (ILMN)|Exact Sciences - PEG Multiple|Growth-Adjusted Market Cap to Net Income revvity.com RVTY|Bio-Rad (BIO) - Price/Earnings to Growth Ratio|NNNN - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio Sterigenics|QuidelOrtho Inc. - Market Cap to Earnings and Growth Ratio|Price/Earnings to Growth Ratio OPKO Health, Inc. (OPK)|Growth-Adjusted Market Cap to Net Income CareDx, Inc.|Maravai LifeSciences Holdings, Inc. - Price/Earnings to Growth Multiple|Fulgent Genetics Inc (FLGT) - Price to Earnings Adjusted for Growth Rate|Fluidigm - PEG Multiple|Cytek Corp (CTKB) - Price/Earnings to Growth Multiple|OSUR: PEG Multiple|Exagen - Growth-Adjusted Payback Ratio|MDXH (MDxHealth) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Lucid Diagnostics, Inc. LUCD|Price/Earnings to Growth Ratio Prenetics Global (PRE)|Price/Earnings to Growth Multiple imdxinc.com IMDX|PEG Multiple TRIB (Trinity Biotech)|prophaselabs.com (PRPH) - Price to Earnings Adjusted for Growth Rate|Ainos - PEG Multiple|CODX (Co-Diagnostics Inc) - Growth-Adjusted P/E Ratio|HSCS: PEG Multiple|BMRA - Growth-Adjusted Market Cap to Net Income|CDIO (Cardio Diagnostics Holdings Inc.) - PEG Multiple|Price/Earnings to Growth Multiple onconetix.gcs-web.com (ONCO)|Price/Earnings to Growth Ratio Virax Biolabs (VRAX)|Growth-Adjusted Market Cap to Net Income Bluejay Diagnostics Inc|Price/Earnings to Growth Ratio Vermillion AWH|AXDX (Accelerate Diagnostics Inc) - Market Cap to Earnings and Growth Ratio|CNTG - Price/Earnings to Growth Ratio|Enzo Biochem, Inc. (ENZ) - Price/Earnings to Growth Multiple|FRES: PEG Multiple|Growth-Adjusted P/E Ratio GENE|Price/Earnings to Growth Ratio 23andMe Inc.